Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

26 September 2020 : Database Analysis  

Prognostic Value of Acute-On-Chronic Liver Failure (ACLF) Score in Critically Ill Patients with Cirrhosis and ACLF

Xinran Lin1ABCDEF, Xielin Huang2ABCDEF, Li Wang1BC, Shuyi Feng1B, Xiaofu Chen1BC, Weimin Cai1B, Zhiming Huang1A*

DOI: 10.12659/MSM.926574

Med Sci Monit 2020; 26:e926574

Table 1 Characteristics of cirrhotic patients in this study, stratified by mortality (n=786, day=28).

VariablesAll patients (n=786) [n (%)]Survivors (n=559) [n (%)]Nonsurvivors (n=227) [n (%)]P value*
Demographic parameters
 Age (years)56 (50–65)56 (49–64)58 (50–67)0.093
 Sex (male) [n (%)]524 (66.7)374 (66.9)150 (66.1)0.050
 Height (cm)172.7 (165.1–178.0)172.7 (165.1–177.8)173.0 (163.0–179.1)0.647
 Weight (kg)84.6 (71.3–99.8)84.2 (71.1–100.0)85.0 (72.0–99.0)0.935
Ethnicity[n (%)]<0.001
 White584 (74.3)427 (76.4)157 (69.2)
 Black61 (7.8)50 (8.9)11 (4.8)
 Other141 (17.9)82 (14.7)59 (26)
Vital signs and treatment
 Heart rate89.2±16.887.9±16.392.4 ±17.60.001
 Respiratory rate (bpm)18 (16–21)18 (15–21)20 (17–23)<0.001
 Temperature (°C)36.7 (36.3–37.1)36.7 (36.4–37.2)36.4 (36.0–36.9)<0.001
 MAP (mmHg)73.7 (67.1–82.2)75.7 (69.5–84.5)69.4 (64.3–75.6)<0.001
 PaO2/FiO2218 (133–367)241 (149–376)174 (99–329)<0.001
 SpO2/FiO2194 (101–250)196 (137–250)162 (99–245)<0.001
 24-h urine output (ml)1182.5 (582.0–1940.0)1360.0 (786.5–2118.5)656.5 (206.0–1338.5)<0.001
 Vasopressin used [n (%)]280 (35.6)156 (27.9)124 (54.6)<0.001
 Ventilator[n (%)]453 (57.6)308 (55.1)145 (63.9)0.024
 RRT [n (%)]68 (8.7)35 (6.3)33 (14.5)<0.001
Cirrhosis complication [n (%)]
 Hepatic encephalopathy214 (27.2)142 (25.4)72 (31.7)0.071
 Ascites215 (27.4)139 (24.9)76 (33.5)0.014
 Variceal bleeding105 (13.4)69 (12.3)36 (15.9)0.189
 Spontaneous bacterial peritonitis68 (8.7)39 (7.0)29 (12.8)0.009
 Hepatorenal syndrome123 (15.6)63 (11.3)60 (26.4)<0.001
Causes of cirrhosis [n (%)]
 Alcoholic411 (52.3)276 (49.4)135 (59.5)0.010
 Biliary17 (2.2)13 (2.3)4 (1.8)0.790
 Hepatitis B27 (3.4)15 (2.7)12 (5.3)0.069
 Hepatitis C259 (33)183 (32.7)76 (33.5)0.841
 Autoimmune12 (1.5)9 (1.6)3 (1.3)1.000
 Other189 (24)132 (23.6)57 (25.1)0.656
ACLF [n (%)]196 (24.9)108 (19.3)88 (38.8)<0.001
Diabetes227 (28.9)164 (29.3)63 (27.8)0.657
Hypertension294 (37.4)216 (38.6)78 (34.4)0.261
Diagnosis at ICU admission
 Acute respiratory failure278 (35.4)152 (27.2)126 (55.5)<0.001
 Acute renal failure425 (54.1)252 (45.1)173 (76.2)<0.001
 Cardiorespiratory arrest19 (2.4)5 (0.9)14 (6.2)<0.001
 Congestive heart failure138 (17.6)96 (17.2)42 (18.5)0.657
 Neurological failure95 (12.1)70 (12.5)25 (11.0)0.556
 Severe sepsis197 (25.1)86 (15.4)111 (48.9)<0.001
 Variceal bleeding105 (13.4)69 (12.3)36 (15.9)0.189
Length of ICU stay3.48 (1.90–7.02)3.24 (1.89–7.02)3.83 (1.90–7.08)0.600
* Student’s t-test or Mann-Whitney U-test was used for continuous variables, and χ-test or Fisher’s exact test was used for categorical variables.
MAP – mean arterial pressure; RRT – renal replacement therapy.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750